Recent updates in COVID-19 with emphasis on inhalation therapeutics: Nanostructured and targeting systems - ScienceDirect

Monoclonal antibody therapies against SARS-CoV-2 - The Lancet Infectious Diseases

Inhaled nano-based therapeutics for pulmonary fibrosis: recent advances and future prospects, Journal of Nanobiotechnology

Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial - The Lancet Respiratory Medicine

Theoretical effectiveness of steam inhalation against SARS-CoV-2 infection: updates on clinical trials, mechanism of actions, and traditional approaches - ScienceDirect

Inhaled corticosteroids: not just for asthma, but for COVID-19? - The Lancet Respiratory Medicine

Localized delivery of nanomedicine and antibodies for combating COVID-19 - ScienceDirect

Nanoparticles as an effective drug delivery system in COVID-19 - ScienceDirect

Insights from nanotechnology in COVID-19 treatment - ScienceDirect

Respiratory sequelae of COVID-19: pulmonary and extrapulmonary origins, and approaches to clinical care and rehabilitation - The Lancet Respiratory Medicine

Understanding on the possible routes for SARS CoV-2 invasion via ACE2 in the host linked with multiple organs damage - ScienceDirect

Nanomedicine strategies to target coronavirus - ScienceDirect

Therapeutic targets and interventional strategies in COVID-19: mechanisms and clinical studies

Therapeutic and diagnostic applications of nanoparticles in the management of COVID-19: a comprehensive overview, Virology Journal

COVID-19-Associated acute respiratory distress syndrome (CARDS): Mechanistic insights on therapeutic intervention and emerging trends - ScienceDirect

Therapeutic advances in COVID-19